12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Posts Tagged ‘NASDAQ:APLS’
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2024 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2024 Earnings Call Transcript February 28, 2025Apellis Pharmaceuticals, Inc. beats earnings expectations.
10 Oversold Pharma Stocks to Buy According to Analysts
On February 20, Emily Field, Head of European Pharma Research at Barclays, appeared on CNBC to discuss the dynamics of the pharmaceutical sector, the impact of US tariffs, and...
12 Most Oversold Healthcare Stocks to Buy Now
Healthcare costs and spending have been rising in the US.
10 Top Insider Stock Buys And Sells In January
Ever heard of the “January effect?” In case you haven’t, a “January effect” is considered a phenomenon in the stock market where stock prices, most commonly of small...
10 Mid-Cap Stocks Insiders Are Selling Recently
Why should investors analyze insider trading activity? Insiders, or people in high positions within a company—such as executives and directors—can have crucial insights into...
Should You Hold Apellis Pharmaceuticals (APLS)?
PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q3 2024 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q3 2024 Earnings Call Transcript November 5, 2024Apellis Pharmaceuticals, Inc. misses on earnings expectations.
Should You Hold Apellis Pharmaceuticals (APLS)?
PGIM Jennison Health Sciences Fund released its second quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
10 Best Mid-Cap Healthcare Stocks To Buy Now
According to projections by ReportLinker, the market for healthcare services will increase from $7.5 trillion in 2022 to $7.975 trillion in 2023.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q2 2024 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q2 2024 Earnings Call Transcript August 1, 2024Apellis Pharmaceuticals, Inc. beats earnings expectations.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q1 2024 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.54 EPS, expectations were $-0.54. Apellis Pharmaceuticals, Inc.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q4 2023 Earnings Call Transcript
Apellis Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.73 EPS, expectations were $-0.66. Apellis Pharmaceuticals, Inc.
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
Below we present the list of 5 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q3 2023 Earnings Call Transcript
Operator: Good morning ladies and gentlemen. Thank you for standing by and welcome to the Apellis Pharmaceuticals Third Quarter 2023 Earnings Conference Call.
Wall Street Analysts See Upside Potential for 5 Stocks with Rising Price Targets
In this article, we discuss the 5 stocks receiving price-target hike from Wall Street analysts.
5 Worst Performing Healthcare Stocks in 2023
In this article, we discuss 5 worst performing healthcare stocks in 2023.
5 Oversold Healthcare Stocks to Buy
In this article, we will take a look at the 5 oversold healthcare stocks to buy.
5 Worst Performing Biotech Stocks in 2023
In this article, we discuss 5 worst performing biotech stocks in 2023.
5 Oversold MidCap Stocks To Buy
In this piece, we will take a look at five oversold midcap stocks to buy.
Wall Street Analysts Are Downgrading These 5 Stocks
In this article, we discuss the 5 stocks receiving downgrades from analysts.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to Apellis Pharmaceuticals Second Quarter 2023 Earnings Conference Call.
5 Oversold NASDAQ Stocks to Buy
In this article, we will take a look at the 5 oversold NASDAQ stocks to buy.
15 Worst Performing NASDAQ Stocks In 2023
In this article, we discuss 15 worst performing NASDAQ stocks in 2023.
5 Oversold Biotech Stocks to Buy
In this article, we will take a look at the 5 oversold biotech stocks to buy.
12 Stocks with Biggest Upside Potential According to Analysts
In this article, we will take a look at the 12 stocks with biggest upside potential according to analysts.
5 Stock Market Forecasts Next 6 Months
Australian stocks also suffered the same fate in 20222, coming under immense pressure as the Reserve Bank of Australia embarked on an aggressive monetary policy tightening.
5 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
11 Best Mid-Cap Healthcare Stocks To Buy Now
In this article, we discuss 11 best mid-cap healthcare stocks to buy now.
15 Best Strong Buy Stocks to Invest In
In this article, we discuss the 15 best strong buy stocks to invest in.
Top 10 Stock Picks of Frank Fu’s CaaS Capital
In this article, we discuss the top 10 stock picks of Frank Fu's CaaS Capital.
Analysts Are Downgrading These 5 Pharmaceutical Stocks
In this article, we present the 5 pharmaceutical stocks that are being downgraded by analysts.
12 Best US Stocks to Buy Now
All major stock benchmarks saw their highest losses in two years in the first quarter of 2022, with the S&P 500 declining 4.6% and the Nasdaq Composite falling 9%.
Did Hedge Funds Get Apellis Pharmaceuticals, Inc. (APLS) Right?
Stocks, especially the once high flying technology stocks, had a lousy start to the new year. QQQ lost 9% of its value in January.
Do Hedge Funds Love Apellis Pharmaceuticals, Inc. (APLS)?
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of...
Is Apellis Pharmaceuticals, Inc. (APLS) Going to Burn These Hedge Funds?
In this article we are going to use hedge fund sentiment as a tool and determine whether Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) is a good investment right now.
Where Do Hedge Funds Stand On Apellis Pharmaceuticals, Inc. (APLS)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is APLS Stock A Buy or Sell?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Apellis Pharmaceuticals, Inc. (APLS): Hedge Funds Taking Some Chips Off The Table
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On Apellis Pharmaceuticals, Inc. (APLS) ?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Are Selling Apellis Pharmaceuticals, Inc. (APLS)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Have Never Been This Bullish On Apellis Pharmaceuticals, Inc. (APLS)
We hate to say this but, we told you so.
Apellis Pharmaceuticals, Inc. (APLS) vs. Hedge Fund Favorites in 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Have Never Been This Bullish On Apellis Pharmaceuticals, Inc. (APLS)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
Is Apellis Pharmaceuticals, Inc. (APLS) Going to Burn These Hedge Funds?
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Hedge Funds Have Never Been This Bullish On Apellis Pharmaceuticals, Inc. (APLS)
Russell 2000 ETF (IWM) lagged the larger S&P 500 ETF (SPY) by nearly 9 percentage points since the end of the third quarter of 2018 as investors worried over the possible ramifications...
Hedge Funds Have Never Been This Bullish On Apellis Pharmaceuticals, Inc. (APLS)
Hedge funds are known to underperform the bull markets but that's not because they are bad at investing.
